![Elizabeth Ng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Ng
Director/Board Member at
OCEAN BIOMEDICAL, INC.
Net worth: 104 376 $ as of 30/07/2026
Profile
Elizabeth Ng is Chief Executive Officer at Ocean Biomedical Holdings, Inc. since 2019.
Ms. Ng is Independent Director at AIRO Group Holdings, Inc. starting 2025.
Ms. Ng is Director at CRISP-HR Therapeutics Inc. Ms. Ng is Executive Director at Ocean Biomedical, Inc. starting 2025.
Formerly, Ms. Ng was Chief Executive Officer & Director at Ocean Biomedical, Inc. from 2023 to 2024.
Ms. Ng was Director-Commercial & Portfolio Strategy at Gilead Sciences, Inc. Ms. Ng was Director-Strategy Development Group at Merck & Co., Inc. Ms. Ng was Senior Director-Portfolio Strategy at BioMarin Pharmaceutical, Inc. from 2010 to 2017.
Ms. Ng was Senior Director Engagement Manager at Strategic Decisions Group.
Ms. Ng was Vice President-Strategy & Business Development at Bioelectric Devices, Inc. Ms. Ng earned an MBA from Stanford University.
Ms. Ng completed undergraduate studies at Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/06/2026 | 15,486 ( 0.06% ) | 104 376 $ | 30/07/2026 |
Elizabeth Ng active positions
| Companies | Position | Start |
|---|---|---|
| OCEAN BIOMEDICAL, INC. | Director/Board Member | 27/03/2025 |
| AIRO GROUP HOLDINGS, INC. | Director/Board Member | 31/05/2025 |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 01/01/2019 |
CRISP-HR Therapeutics Inc.
 CRISP-HR Therapeutics Inc. Internet Software/ServicesTechnology Services Develops CRISPR platform to create novel therapeutics for rare diseases | Director/Board Member | - |
Former positions of Elizabeth Ng
| Companies | Position | End |
|---|---|---|
| OCEAN BIOMEDICAL, INC. | Chief Executive Officer | 22/10/2024 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 31/12/2016 |
Strategic Decisions Group
 Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Provides consulting solutions | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Elizabeth Ng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Strategic Decisions Group
Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Provides consulting solutions | Commercial Services |
Ocean Biomedical, Inc. (United States)
Ocean Biomedical, Inc. (United States) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bioelectric Devices, Inc.
 Bioelectric Devices, Inc. Miscellaneous Commercial ServicesCommercial Services Develops AI driven bioelectronics | Commercial Services |
CRISP-HR Therapeutics Inc.
CRISP-HR Therapeutics Inc. Internet Software/ServicesTechnology Services Develops CRISPR platform to create novel therapeutics for rare diseases | Technology Services |
AIRO Group Holdings, Inc.
 AIRO Group Holdings, Inc. Aerospace & DefenseElectronic Technology Manufactures and sells drones, military and civil aircraft, flights & offers pilot training services | Electronic Technology |
Ocean Biomedical, Inc.
 Ocean Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Elizabeth Ng
